| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.06 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.096 | 0.06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.097 | 0.07 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |